You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指倒升逾200點重越22,900 騰訊倒升近4% 藥明生物及信義玻璃漲逾半成
本港疫情繼續惡化,傳港府計劃在3月17日以後推行全民強制檢測,期間配合「禁足」,港股繼三連跌昨天曾挫至22,406創近兩年低喘定並收窄跌幅後,今早高開26點,最高見22,817無以爲繼,午後初段曾倒跌121點低見22,591獲承接,再度節節抽升,現報22,937,回升224點或1%,成交額893億元。 藍籌股普遍反彈,尤其是藥明生物(02269.HK)及信義玻璃(00868.HK)漲逾半成,報67.7元及21.85元;騰訊(00700.HK)倒升3.9%曾高見439元;銀娛(00027.HK)、安踏(02020.HK)、碧桂園服務(06098.HK)、海底撈(06862.HK)、金沙(01928.HK)、京東(09618.HK)及瑞聲(02018.HK)也升逾2%-4%,後者最強報22.3元。 然而,舜宇(02382.HK)跌逾2%低見180.3元創逾七個月低。信義光能(00968.HK)、新世界發展(00017.HK)、去年少賺26%遜預期維持派息1.21元中電(00002.HK),以及石藥(01093.HK)也跌逾1%-2%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account